hotspot -WSS

hotspot

author：knowledge 2025-10-06 19:47:08 - browse：58

An army of wooden figures under blue and pink lighting — biotech coverage from STAT — Adobe

Biotech startup ReNAgade Therapeutics is cutting staff just seven months after raising the largest Series A round in the industry this year.

ReNAgade launched in May with hopes of becoming a one-stop shop for medicines targeting RNA, the genetic blueprints that cells use to make proteins instrumental in numerous diseases. These types of medicines are in high demand following the advent of mRNA vaccines for Covid and RNA-silencing therapies made by companies like Alnylam Pharmaceuticals.

ReNAgade was able to capitalize on that excitement when it raised a $300 million Series A round led by MPM Capital’s BioImpact Capital and F2 Ventures. But in recent days, the company decided to lay off around 10% of its 100-person team, according to a company statement and former employees’ posts on social media.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Dobbs anniversary: the lost opportunity of abortion as health care
Next article： At ASCO, pharma leaders speak of advances in 'smart bomb' drugs

focus

WSS

At ASCO, pharma leaders speak of advances in 'smart bomb' drugs

Correcting Robert F. Kennedy Jr.'s vaccine 'facts'

Change Healthcare can notify patients about the breach, HHS says

UpToDate has a racism problem: Dr. Stanley Goldfarb

A letter from the executive editor: The 2023 STATUS List

Grandmother of French teen shot dead by police officer pleads with rioters to stop the violence

hotspot

hotspot

Wikipedia

State Dept. review finds Biden bears some blame for Afghanistan failures

Innovation in antibiotics is ailing. 'Brain drain' may kill it

In Memoriam: Notable people who died in 2023

Prescription digital therapeutics are key to pharma’s future

Medical leaders decry Supreme Court decision on affirmative action

Being 'nonadherent' patient made me a more empathetic doctor

At least 13 dead in Texas as scorching temps continue

ASCO: Palliative care found as helpful given virtually as in person

Dobbs anniversary: the lost opportunity of abortion as health care

Ultragenyx gene therapy for rare liver ailment succeeds in late

knowledge

Archived: an online chat discussing Ebola, vaccines, and a new epidemic

How Robert F. Kennedy Jr. distorted vaccine science

Security flaws in third

Beware reading your test results before your doctor does

Let's speed up science by embracing open access publishing

Crowdfunding for unproven stem cell procedures spreads misinformation

entertainment

focus

focus

hotspot